PRKDC and hepatocellular carcinoma: For example, Long et al. investigated the risk effects of XRCC7P on hepatocellular carcinoma (HCC) and found that these individuals carrying XRCC7-GG would face higher cancer risk than those with XRCC7-TT (adjusted OR = 5.04, P < 0.001) [17].